Skip to main content
Clinical Trials/IRCT20160301026866N7
IRCT20160301026866N7RecruitingPhase 3

Comparison the effect of intranasal dexmedetomidine and remifentanil on reduction of hemodynamic changes after intubation in children ages 6 to 12 years old under general anesthesia

Esfahan University of Medical Sciences0 sites105 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
105

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
6 years to 12 years (—)
Sex
All

Inclusion Criteria

  • all children ages 6 to 12 years of age with general anesthetics, ASAI and ASAII grades, and consent from the parents of the patient to participate in the study.

Exclusion Criteria

  • The criteria for not attending the study include children under 6 years of age and over 12 years of age, underlying illness (inherited and genetic diseases, metabolic diseases, etc.), and parents' disagreement for participation in the study

Investigators

Similar Trials

Intranasal Dexmedetomidine and... | Clinical Trial